CVE-2022-24309

Description

A vulnerability has been identified in Mendix Runtime V7 (All versions < V7.23.29), Mendix Runtime V8 (All versions < V8.18.16), Mendix Runtime V9 (All versions < V9.13 only with Runtime Custom Setting *DataStorage.UseNewQueryHandler* set to False). If an entity has an association readable by the user, then in some cases, Mendix Runtime may not apply checks for XPath constraints that parse said associations, within apps running on affected versions. A malicious user could use this to dump and manipulate sensitive data.

Category

6.8
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.16%
Vendor Advisory siemens.com Vendor Advisory siemens.com
Affected: Siemens Mendix Runtime V7
Affected: Siemens Mendix Runtime V8
Affected: Siemens Mendix Runtime V9
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-24309?
CVE-2022-24309 has been scored as a medium severity vulnerability.
How to fix CVE-2022-24309?
To fix CVE-2022-24309, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-24309 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-24309 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-24309?
CVE-2022-24309 affects Siemens Mendix Runtime V7, Siemens Mendix Runtime V8, Siemens Mendix Runtime V9.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.